Distinguished in Migraine with Brainstem Aura

Wojciech P. Kozubski

49, Przybyszewskiego St, 
Poznan, WP, PL 
Distinguished in Migraine with Brainstem Aura
49, Przybyszewskiego St, 
Poznan, WP, PL 
OverviewLocationsClinical Research

Overview

Wojciech Kozubski practices in Poznan, Poland. Mr. Kozubski is rated as a Distinguished expert by MediFind in the treatment of Migraine with Brainstem Aura. His top areas of expertise are Migraine with Brainstem Aura, Familial Hemiplegic Migraine, Migraine, and Alzheimer's Disease.

His clinical research consists of co-authoring 145 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Migraine with Brainstem Aura.

Gender
Male

Locations

49, Przybyszewskiego St, Poznan, WP 60355, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Oral CLADribine in Patients That Change From First-line Disease Modifying Treatments for Multiple Sclerosis: a pROspective effectivenesS and Safety Study (CLAD CROSS)
Oral CLADribine in Patients That Change From First-line Disease Modifying Treatments for Multiple Sclerosis: a pROspective effectivenesS and Safety Study (CLAD CROSS)
Enrollment Status: Completed
Publish Date: June 24, 2025
Intervention Type: Drug
Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical Trials (CLASSIC-MS)
Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical Trials (CLASSIC-MS)
Enrollment Status: Completed
Publish Date: October 31, 2023
Intervention Type: Other
Study Drug: Cladribine
Study Phase: Phase 4
View 1 Less Clinical Trial

145 Total Publications

CACNA1A Genetic Variants and Their Potential Involvement in Migraine Pathogenesis.
CACNA1A Genetic Variants and Their Potential Involvement in Migraine Pathogenesis.
Journal: International journal of molecular sciences
Published: July 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kozubski's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile